The SARS-CoV-2 virus causes Coronavirus Disease (COVID-19), an infectious disease.
The majority of patients infected with COVID-19 will have mild to moderate symptoms and will recover without any additional therapy. Some, on the other hand, will become critically unwell and require medical assistance.
The virus spreads in minute liquid particles from an infected person’s lips or nose when they cough, sneeze, speak, sing, or breathe. The particles range in size from larger respiratory droplets to tiny aerosols.
If you are in close proximity to someone who has COVID-19, you can become infected by inhaling the virus or by touching your eyes, nose, or mouth after coming into contact with a contaminated surface. Indoors and in crowded locations, the virus is more easily disseminated.
The following are the most prevalent symptoms:
fever \scough \stiredness
a loss of scent or taste
Sore throat and a skin rash are less common symptoms.
Today, there are more treatment options for COVID 19. The FDA recently approved one drug treatment for COVID-19 and authorized others for emergency use during this scenario, the antiviral drug Remdesivir (Remdesivir) injection for adults and certain pediatric COVID-19 patients who are sick enough to require hospitalization.
Sriya Life Science is Remdesivir Bulk Pharma Exporter. They are pharmaceutical third-party manufacturers who work as pharmaceutical exporters and medical providers in nations including Brazil, Cambodia, Venezuela, the Philippines, Nigeria, Seychelles, and Sudan. Remdesivir (Remdesivir Injection) is a dual-action antibiotic and antiviral drug. It helps with bacterial infections. The skin, lungs, stomach, and urinary system are all affected by this bacterial illness.